RFG
BSX icon

REAP Financial Group’s Boston Scientific BSX Stock Holding History

REAP Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-718
Closed -$45.1K – 545
2026
Q1 		$45.1K Buy
718
+49
+7% +$3.92K 0.01% 300
2025
Q4 		$63.8K Buy
669
+119
+22% +$11.7K 0.01% 269
2025
Q3 		$53.7K Buy
550
+56
+11% +$5.8K 0.01% 259
2025
Q2 		$53.1K Buy
494
+317
+179% +$32.1K 0.01% 261
2025
Q1 		$17.9K Buy
177
+41
+30% +$4.13K ﹤0.01% 315
2024
Q4 		$12.1K Sell
136
-40
-23% -$3.52K ﹤0.01% 348
2024
Q3 		$14.7K Buy
176
+39
+28% +$3.07K ﹤0.01% 305
2024
Q2 		$10.6K Buy
137
+42
+44% +$3.07K ﹤0.01% 334
2024
Q1 		$6.51K Sell
95
-5
-5% -$321 ﹤0.01% 418
2023
Q4 		$5.78K Buy
+100
New +$5.34K ﹤0.01% 450

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

REAP Financial Group's BSX Position: Q2 2026 in Review

REAP Financial Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 718 shares — an estimated $45.1K sold.

REAP Financial Group first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $63.8K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • REAP Financial Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • REAP Financial Group sold 718 Boston Scientific shares in Q2 2026, an estimated $45.1K.
  • REAP Financial Group first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
  • REAP Financial Group's Boston Scientific position peaked at $63.8K in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.